At least one child containing DNA from three distinct people has been conceived to parents in the United Kingdom eight years after the technology was given the government’s blessing. While the announcement isn’t technically ‘new’ information. The Guardian’s reporters were able to obtain an official confirmation by submitting a freedom of information request.
The mitochondrial replacement therapy (MRT), a unique type of in vitro fertilisation (IVF) intended to prevent serious genetic problems in future children. It was invented by the University of Newcastle in partnership with the Newcastle Fertility Centre.
Babies conceived via this technique are created from the fertilisation of a single sperm and a single egg. This is just like any other human.
The link between the nuclear material, which contains the vast majority of the genes responsible for creating a person. And the negligible amount of non-nuclear DNA, which contributes to the formation of the cell’s power plants. This is known as mitochondria, is where they diverge.
The majority of individuals get their nucleus and a lot of mitochondria from their mother’s egg. These children, however, receive their supply of mitochondria from a donated egg.
Only 0.1 percent of the child’s DNA will ultimately come from the donor. Unlocking Life’s Possibilities: Mitochondrial DNA techniques offer hope for individuals battling severe mitochondrial disorders.
The UK was the first country in the world to authorise the use of MRT. But the instances have been kept confidential to ensure everyone’s safety and privacy.
“The Newcastle team responsible for conducting these tests are careful and ultimately wanted to gather at the very least some subsequent information on the infants, while maintaining the confidentiality of the family members,” says stem cell biologist and developmental geneticist Robin Lovell-Badge from the Francis Crick Institute, who wasn’t involved in the cases.
“This in and of itself is a difficulty. It will be intriguing to discover how effectively the MRT approach succeeded in practise, whether the infants are clear of mitochondrial disease, whether there is a chance that they would experience issues later in life, or, if they are female, whether their children are at risk of inheriting the disease later in life.
For example, a few instances in evidence of concept studies indicate that a mother’s mitochondrial DNA may nonetheless predominate in offspring born utilising MRT.
Visit CxO Global FORUM or CxO News Live for all the latest updates.
